Edition:
United States

ENDRA Life Sciences Inc (NDRA.OQ)

NDRA.OQ on NASDAQ Stock Exchange Capital Market

2.62USD
22 Jun 2018
Change (% chg)

$0.11 (+4.38%)
Prev Close
$2.51
Open
$2.49
Day's High
$2.80
Day's Low
$2.31
Volume
7,085
Avg. Vol
13,516
52-wk High
$5.88
52-wk Low
$1.57

Latest Key Developments (Source: Significant Developments)

Endra Life Sciences Enters Into Amendment To Certain Collaborative Research Agreement With GE
Monday, 5 Feb 2018 09:24am EST 

Feb 5 (Reuters) - General Electric Co ::ENDRA LIFE SCIENCES INC - ON JAN 30, CO ENTERED INTO AMENDMENT TO CERTAIN COLLABORATIVE RESEARCH AGREEMENT WITH GE, DATED AS OF APRIL 22, 2016.ENDRA LIFE SCIENCES SAYS ‍RENEWED RESEARCH AGREEMENT WITH GE, ACTING THROUGH GE HEALTHCARE UNIT BY EXTENDING AGREEMENT'S TERM TO JAN 2020 - SEC FILING​.  Full Article

ENDRA Life Sciences reports Q3 loss per share $0.23
Wednesday, 15 Nov 2017 08:47am EST 

Nov 15 (Reuters) - ENDRA Life Sciences Inc :Q3 loss per share $0.23.  Full Article

‍Longboard Capital Advisors LLC​ reports 16.7 pct passive stake in Endra Life Sciences as on May 9
Thursday, 13 Jul 2017 12:34pm EDT 

July 13 (Reuters) - Endra Life Sciences Inc ::‍Longboard Capital Advisors LLC​ reports 16.7 percent passive stake in Endra Life Sciences Inc as on May 9, 2017 - SEC filing.  Full Article

Endra Life Sciences prices initial public offering
Tuesday, 9 May 2017 08:00am EDT 

May 9 (Reuters) - Endra Life Sciences Inc ::Endra Life Sciences Inc. prices initial public offering.Endra Life Sciences- pricing of initial public offering of 1.7 million units, at an offering price of $5.00 per unit.  Full Article

BRIEF-Endra Life Sciences Enters Into Amendment To Certain Collaborative Research Agreement With GE

* ENDRA LIFE SCIENCES INC - ON JAN 30, CO ENTERED INTO AMENDMENT TO CERTAIN COLLABORATIVE RESEARCH AGREEMENT WITH GE, DATED AS OF APRIL 22, 2016

No consensus analysis data available.